Barriers and motivations to volunteers' participation in preventive vaccine trials: a systematic review

被引:19
作者
Detoc, M. [1 ,2 ]
Gagneux-Brunon, A. [1 ,2 ]
Lucht, F. [1 ,2 ]
Botelho-Nevers, E. [1 ,2 ]
机构
[1] Univ Hosp St Etienne, INSERM, Clin Trial Ctr, CIC 1408, St Etienne, France
[2] Univ Lyon, Med Sch St Etienne, Grp Immun Muqueuse & Agents Pathogenes GIMAP, EA3064, St Etienne, France
关键词
Vaccine; clinical trials; motivations; barriers; participation; recruitment; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIALS; DECISION-MAKING; BLOOD-DONATION; PATIENT; PEOPLE; WILLINGNESS; RECRUITMENT; ENROLLMENT; ATTITUDES;
D O I
10.1080/14760584.2017.1297706
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The recruitment of volunteers in preventive vaccine trials (PVT) is a challenge, since vaccine hesitancy and debates on vaccines are combined to usual difficulties of enrollment in clinical trials.Areas covered: Current knowledge of the reasons leading to the volunteers' participation or non-participation in PVT mainly focuses on data from preventive HIV vaccine trials. A systematic PubMed search was conducted using PRISMA guidelines to identify articles or reviews that reported barriers and motivations to participation in PVT regardless of the targeted disease or population.Expert commentary: In view of the barriers and motivations reviewed here, improvements in recruitment could be made through a better explanation of the prevented disease, of the expected individual and collective benefit and of all ethical protective principles associated to the trials. Use of decision aids as well as patient and public involvement may improve given information and may enhance comprehension of participants and their participation in PVT. Further prospective and interventional studies are needed to analyze if these leads may improve acceptation level in PVT.
引用
收藏
页码:467 / 477
页数:11
相关论文
共 63 条
[1]  
Abolghasemi Hassan, 2010, Asian J Transfus Sci, V4, P9, DOI 10.4103/0973-6247.59385
[2]   Difficulties of recruitment for a randomized controlled trial involving influenza vaccination in healthy older people [J].
Allsup, SJ ;
Gosney, MA .
GERONTOLOGY, 2002, 48 (03) :170-173
[3]   Why healthy subjects volunteer for phase I studies and how they perceive their participation? [J].
Almeida, Luis ;
Azevedo, Benedita ;
Nunes, Teresa ;
Vaz-da-Silva, Manuel ;
Soares-da-Silva, Patricio .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) :1085-1094
[4]   Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials [J].
Andrasik, Michele Peake ;
Yoon, Ro ;
Mooney, Jessica ;
Broder, Gail ;
Bolton, Marcus ;
Votto, Teress ;
Davis-Vogel, Annet .
PREVENTION SCIENCE, 2014, 15 (03) :268-276
[5]  
[Anonymous], MONDE
[6]  
[Anonymous], BMC PUBLIC HLTH
[7]  
[Anonymous], 2001, B WORLD HEALTH ORGAN
[8]  
[Anonymous], COCHRANE DB SYST REV
[9]   Attitudes towards immunization [J].
Balinska, M. -A. ;
Leon, C. .
REVUE DE MEDECINE INTERNE, 2007, 28 (01) :28-32
[10]   Community attitudes to remunerated blood donation in Australia: results from a national telephone survey [J].
Bambrick, Hilary ;
Gallego, Gisselle .
TRANSFUSION MEDICINE, 2013, 23 (05) :302-308